Timeline
Maryline Bourgine
Research Engineer
07 Sep 2023
publication
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Read more18 Apr 2023
publication
Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication.
Read more01 Jan 2023
publication
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.
Read more21 Dec 2022
publication
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
Read more27 Apr 2022
publication
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Read more16 Dec 2021
publication
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
Read more07 Dec 2021
publication
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Read more29 Jul 2021
18 Apr 2021
16 Dec 2020
publication
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Read more24 Jun 2020
publication
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.
Read more23 Jul 2015
publication
Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes
Read more16 Dec 2014
publication
Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?
Read more26 Nov 2014
publication
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
Read more19 Mar 2014
publication
Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection
Read more26 Dec 2013
publication